TUMOR ANTIGEN-TARGETED T-CELL THERAPY FOR METASTATIC BREAST CANCER

$2,711,356FY2014Department of the ArmyDOD

Sloan-Kettering Institute For Cancer Research

Investigators

View source on USAspending →